Basel, Basel-Stadt, Switzerland In 1896 was created Roche, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Basel. The company was established in Europe in Switzerland.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Roche, startups are often financed by OrbiMed, Novo Holdings, Life Sciences Partners. The meaningful sponsors for the fund in investment in the same round are GBS Ventures, No 8 Ventures, Stripes. In the next rounds fund is usually obtained by No 8 Ventures, GBS Ventures, New Zealand Venture Investment Fund.
The important activity for fund was in 2016. Comparing to the other companies, this Roche performs on 4 percentage points more the average number of lead investments. The higher amount of exits for fund were in 2018. Considering the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The average startup value when the investment from Roche is more than 1 billion dollars. The common things for fund are deals in the range of 50 - 100 millions dollars.
For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Flatiron Health, C4 Therapeutics, Proacta. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Software, Medical.
Besides them, we counted 34 critical employees of this fund in our database.
Related Funds
| Fund Name | Location |
| Andre Agassi Foundation for Education | Las Vegas, Nevada, United States |
| Angel Ventures Peru | Lima, Lima, Peru |
| Asia America MultiTechnology Association (AAMASV) | California, Palo Alto, United States |
| BOC & Utrust Private Equity Fund Management | China, Guangdong, Guangzhou |
| Chenhui Venture Partners | China, Shanghai |
| DFJ Portage Ventures | Minnesota, Northfield, United States |
| Floret Ventures | California, San Francisco, United States |
| Florida Growth Fund | Florida, Fort Lauderdale, United States |
| Fuxin Dinghong | China, Fuxin, Liaoning |
| Jiantou Jiachi Touzi | China, Hongkou District |
| KIBOW | - |
| Major League Soccer | New York, New York, United States |
| Nicol Investment Company | Nashville, Tennessee, United States |
| Shanghai Capital | China, Shanghai |
| Teranga Capital | Dakar, Dakar Region, Senegal |
| The Canada Life Assurance Company | Canada, Ontario, Toronto |
| The E.W. Scripps Company | Cincinnati, Ohio, United States |
| TOKAI TELEVISION BROADCASTING | Aichi Prefecture, Japan, Nagoya |
| Valor Ventures | Atlanta, Georgia, United States |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Sentient Med | 01 Jul 2021 | Herzliya, Tel Aviv, Israel | |||
C4 Therapeutics | $73M | 07 Jan 2016 | Cambridge, Massachusetts, United States | ||
Flatiron Health | $175M | 06 Jan 2016 | New York, United States | ||
Proacta | $35M | 07 Feb 2007 | San Diego, California, United States | ||
Proacta | $7M | 11 Sep 2006 | San Diego, California, United States | ||
Proacta | $1M | 26 Jul 2004 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Sentient Med | 01 Jul 2021 | Herzliya, Tel Aviv, Israel | |||
C4 Therapeutics | $73M | 07 Jan 2016 | Cambridge, Massachusetts, United States | ||
Flatiron Health | $175M | 06 Jan 2016 | New York, United States | ||
Proacta | $35M | 07 Feb 2007 | San Diego, California, United States | ||
Proacta | $7M | 11 Sep 2006 | San Diego, California, United States | ||
Proacta | $1M | 26 Jul 2004 | San Diego, California, United States |
